Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Andrea M Harris
Introduction
Andrea M Harris is an accomplished inventor based in Frederick, MD, USA. With a solid track record of innovation, she has been recognized for her significant contributions to the field of biomedicine, particularly in the development of vaccines and therapeutic compositions.
Latest Patents
Andrea M Harris holds two notable patents that showcase her expertise in the realm of molecular biology. The first patent, titled "Nucleic acid sequence and uses thereof," reveals the Neisseria spp. NGSP polypeptide and its derivatives. This invention includes nucleotide sequences encoding these polypeptides and antibodies that specifically bind them. The patent also describes various prophylactic and therapeutic compositions, such as vaccines, utilizing the NGSP polypeptide or its derivatives. Furthermore, it outlines methods to induce an immune response to Neisseria in animals.
The second patent, "Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof," centers around the NMASP polypeptide. Similar to her first patent, it includes polypeptides derived from NMASP, nucleotide sequences, and specific antibodies. This innovation also reveals immunogenic compositions, including vaccines that generate a crucial immune response against NMASP in animals.
Career Highlights
Andrea M Harris is currently associated with Antex Biologics, Inc., where she has made significant strides in vaccine development. Her work has not only advanced scientific understanding but has also contributed to public health initiatives.
Collaborations
During her career, Andrea has collaborated with various professionals, including W James Jackson, further amplifying her innovative impact in the biotechnology field. These partnerships have fostered an environment of creativity and knowledge exchange, centering around advancements in immunology and vaccine research.
Conclusion
Andrea M Harris stands as a prominent figure in the world of biomedical innovation, with her patents laying the groundwork for potential breakthroughs in vaccine development. Her dedication to researching and developing therapeutic solutions places her at the forefront of public health advancements, making her an invaluable asset to the scientific community.